TAK1 signaling is a potential therapeutic target for pathological angiogenesis
Linxin Zhu, Suraj Lama, Leilei Tu, Gregory J Dusting, Jiang-Hui Wang, Guei-Sheung Liu
ANGIOGENESIS | SPRINGER | Published : 2021
Angiogenesis plays a critical role in both physiological responses and disease pathogenesis. Excessive angiogenesis can promote neoplastic diseases and retinopathies, while inadequate angiogenesis can lead to aberrant perfusion and impaired wound healing. Transforming growth factor β activated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase family, is a key modulator involved in a range of cellular functions including the immune responses, cell survival and death. TAK1 is activated in response to various stimuli such as proinflammatory cytokines, hypoxia, and oxidative stress. Emerging evidence has recently suggested that TAK1 is intimately involved in angioge..View full abstract
Awarded by National Health and Medical Research Council of Australia
Awarded by National Natural Science Foundation of China
The authors thank Ms Jessika Hernandez Garcia for assistance with figure illustrations. This work was supported by grants from the National Health and Medical Research Council of Australia (1185600) and the National Natural Science Foundation of China (82000902). The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government.